SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BORGATTI, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.128
AS - Asia 15.311
EU - Europa 12.546
SA - Sud America 2.503
Continente sconosciuto - Info sul continente non disponibili 710
AF - Africa 342
OC - Oceania 50
AN - Antartide 1
Totale 59.591
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.435
SG - Singapore 5.575
FI - Finlandia 4.212
CN - Cina 4.128
BR - Brasile 1.978
IT - Italia 1.926
VN - Vietnam 1.549
DE - Germania 1.327
HK - Hong Kong 1.220
UA - Ucraina 1.198
PL - Polonia 1.187
TR - Turchia 816
GB - Regno Unito 757
SE - Svezia 501
FR - Francia 494
RU - Federazione Russa 372
JP - Giappone 364
CA - Canada 329
IN - India 328
BD - Bangladesh 307
ID - Indonesia 239
MX - Messico 209
AR - Argentina 178
NL - Olanda 135
ZA - Sudafrica 119
IQ - Iraq 104
PK - Pakistan 96
EC - Ecuador 90
ES - Italia 84
CO - Colombia 79
PH - Filippine 65
VE - Venezuela 62
MY - Malesia 61
BE - Belgio 59
IR - Iran 57
UZ - Uzbekistan 54
SA - Arabia Saudita 52
MA - Marocco 47
LT - Lituania 43
CL - Cile 42
AE - Emirati Arabi Uniti 40
AT - Austria 40
AU - Australia 37
JM - Giamaica 33
TN - Tunisia 33
PY - Paraguay 32
KE - Kenya 31
CH - Svizzera 30
KR - Corea 30
CZ - Repubblica Ceca 28
EG - Egitto 28
GR - Grecia 24
CR - Costa Rica 22
TH - Thailandia 22
JO - Giordania 21
IE - Irlanda 18
IL - Israele 18
NP - Nepal 17
ET - Etiopia 16
PE - Perù 16
TW - Taiwan 16
DZ - Algeria 15
LB - Libano 15
OM - Oman 15
PT - Portogallo 15
AZ - Azerbaigian 14
HN - Honduras 14
KZ - Kazakistan 14
RO - Romania 14
LV - Lettonia 13
PA - Panama 13
SV - El Salvador 12
UY - Uruguay 12
BO - Bolivia 11
DO - Repubblica Dominicana 11
TT - Trinidad e Tobago 11
NG - Nigeria 10
NZ - Nuova Zelanda 10
BG - Bulgaria 9
BH - Bahrain 9
KG - Kirghizistan 9
GT - Guatemala 8
LY - Libia 8
NI - Nicaragua 8
PS - Palestinian Territory 8
RS - Serbia 8
AL - Albania 7
BB - Barbados 7
HU - Ungheria 7
KW - Kuwait 7
SI - Slovenia 7
AO - Angola 6
GE - Georgia 6
MN - Mongolia 6
SY - Repubblica araba siriana 6
EE - Estonia 5
EU - Europa 5
MD - Moldavia 5
CY - Cipro 4
HR - Croazia 4
Totale 58.798
Salva come PNG Salva come JPEG
Città #
Helsinki 3.850
Singapore 3.460
Ashburn 3.070
Woodbridge 2.259
San Jose 2.106
Fairfield 1.905
Beijing 1.481
Chandler 1.407
Jacksonville 1.366
Ann Arbor 1.296
Houston 1.230
Hong Kong 1.196
Santa Clara 1.177
Warsaw 1.169
Council Bluffs 858
Wilmington 804
Seattle 778
Cambridge 630
Ferrara 518
Ho Chi Minh City 509
Izmir 477
New York 438
Los Angeles 429
Nanjing 425
Dallas 416
Hanoi 361
Tokyo 340
Princeton 326
Lauterbourg 273
Munich 255
Boardman 234
Milan 196
Shanghai 177
Jakarta 162
San Diego 158
São Paulo 158
Bremen 154
Addison 151
Bologna 145
Nanchang 123
Mexico City 122
Shenyang 120
Orem 106
London 100
Toronto 100
Tianjin 93
Turku 93
Phoenix 90
Brooklyn 88
Changsha 85
Chicago 84
Hebei 84
Montreal 82
Redwood City 82
Buffalo 81
Porto Alegre 79
Chennai 78
Da Nang 75
Hefei 74
Rio de Janeiro 74
Falls Church 73
Rome 70
Denver 69
Jiaxing 68
Frankfurt am Main 67
Moscow 66
Johannesburg 64
San Francisco 64
Stockholm 64
Haiphong 63
Guangzhou 61
Dearborn 60
The Dalles 59
Atlanta 57
Brussels 56
Mountain View 54
Jinan 51
Falkenstein 49
Tashkent 49
Baghdad 47
Poplar 46
Auburn Hills 45
Boston 42
Hangzhou 42
Manchester 42
Verona 41
Belo Horizonte 38
Guayaquil 38
Philadelphia 38
Des Moines 37
Mumbai 37
Norwalk 37
Brasília 36
Zhengzhou 36
Curitiba 35
Dong Ket 35
Ningbo 34
Nuremberg 34
Ferrara di Monte Baldo 33
San Mateo 33
Totale 40.227
Salva come PNG Salva come JPEG
Nome #
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.031
Use of angelicin and of its structural analogues for the treatment of thalassemia 1.981
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 424
A validated cellular biobank for β-thalassemia 421
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 387
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 381
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 375
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 374
CARATTERIZZAZIONE CHIMICA E BIOATTIVITÀ DI PREPARAZIONI TRADIZIONALI DI DROGHE AYURVEDICHE: HEMIDESMUS INDICUS E AZADIRACHTA INDICA 313
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 313
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 310
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 302
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 289
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 282
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 272
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 272
SPR-based non-invasive prenatal testing for fetal sex determination 270
A dielectrophoretic microchip for controlled cell targeting with functionalized microspheres 268
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 263
Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity 263
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 258
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 256
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 256
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 251
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 250
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 247
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 246
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 243
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA 243
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 242
Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines 239
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 239
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 238
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 235
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 233
Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum 232
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 231
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 231
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 231
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 230
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 230
Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin 230
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 229
Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences 228
Expression of Pro-inflammatory Interleukin-8 is Reduced by Ayurvedic Decoctions 228
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 227
Targeting Transcription Factor Activity as a Strategy to Inhibit Pro-Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds 227
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 226
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 225
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 223
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 223
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 222
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 222
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 220
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 219
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 218
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 217
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells 214
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 213
Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites 212
A NOVEL USE OF RAPAMYCN AND STRUCTURAL ANALOGUES THEREOF 211
Digital microfluidic devices for isothermal circular strand displacement polymerization of microRNAs 210
Regulation of IL-8 gene expression in gliomas by microRNAs 210
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 209
Liposomes as carriers for DNA-PNA hybrids 208
Antiproliferative and Erythroid Differentiation Activities of Cedrus libani Seed Extracts against K562 Human Chronic Myelogenus Leukemia Cells 208
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 207
Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles 205
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 205
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 205
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 204
New trends in non-invasive prenatal diagnosis: Applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells (Review) 202
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 202
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 200
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 200
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 198
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 198
Cellular biosensors for the identification of fetal hemoglobin inducers 197
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 197
Cellulose acetate microparticles for Lab-on-a-chip applications 195
Alteration of microRNA biological activity with peptide nucleic acid 195
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 195
Plants with antitumor properties:from biologically active molecules to drugs 194
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 194
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 194
Gene Modulation by Peptide Nucleic Acids (PNAs) Targeting microRNAs (miRs) 192
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 192
Development of microRNA based protocols for detection of autologous blood transfusion in sport 192
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 190
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 189
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 187
"Lethal kiss” on a dielectrophoresis (DEP) based Lab-on-a-chip device: two-colour real-time determination of cytotoxic T-lymphocyte activity. 186
Development and molecular characterization of transgenic mice for beta-thalassemia 185
Effects of Medicinal Plant Extracts on Molecular Interactions between DNA and Transcription Factors 185
Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites 185
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 184
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 184
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 182
Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site 182
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 182
Totale 26.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 253.080
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.396
Totale 260.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.619 0 0 157 105 212 161 156 139 126 279 349 935
2022/20233.300 353 266 81 444 569 447 150 298 367 33 160 132
2023/20241.875 142 262 79 49 211 366 119 87 31 30 76 423
2024/20257.091 182 189 580 355 789 556 239 381 1.199 816 955 850
2025/202623.264 1.905 791 1.605 2.377 2.748 1.285 2.384 1.167 5.634 2.270 753 345
2026/20272.650 575 1.201 874 0 0 0 0 0 0 0 0 0
Totale 59.591